Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
CRITICAL RISK
Score updated Aug 28, 2026

ASBP — Aspire Biopharma Holdings, Inc. Dilution Risk Tracker

Track ASBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ASBP — Get alerts when the score changes →

As of August 28, 2026, Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. Aspire Biopharma Holdings, Inc. has a market capitalization of $7.11M, 1.40M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $20.00M, 44.00M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
25
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 52%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 3137% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 144% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise model 20%
• Active shelf registration ($20M, 281% of market cap)
🔔 Track ASBP — Get forecast alerts →

Market Data

Market Cap$7.11M
Shares Outstanding1.40M
Float1.20M
Cash$12.17M
Debt$1.50M
Short InterestN/A

Institutional Holdings

10 institutional holders · 12.5K shares
#1 UBS Group AG 6.4K shares
#2 Morgan Stanley 2.6K shares
#3 Geode Capital Management, LLC 1.4K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest79.9K
Days to Cover1.5
% of Float6.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2024-12-31
8-K 8K EVENT 2026-06-22
8-K/A 8K EVENT 2026-04-17
8-K 8K EVENT 2026-04-16
Full SEC filing analysis available with free account

Recent News

Factual ASBP Dilution Snapshot

Aspire Biopharma Holdings, Inc. (ASBP) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ASBP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ASBP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ASBP
ASBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.